Home › Funds › BOOTHBAY FUND MANAGEMENT, LLC › RVMD

BOOTHBAY FUND MANAGEMENT, LLC position in RVMD

REVOLUTION MEDICINES INC · Health Care

BOOTHBAY FUND MANAGEMENT, LLC reported holding 458,954 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$94.2M, representing 2.32% of its reported portfolio and ranking #1 among its reported holdings. BOOTHBAY FUND MANAGEMENT, LLC has disclosed RVMD holdings in 8 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)458.95K sh
Reported value held$94.20M
Portfolio Weight2.32%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How BOOTHBAY FUND MANAGEMENT, LLC's RVMD position evolved

BOOTHBAY FUND MANAGEMENT, LLC first disclosed a stake in RVMD in Q3 2023 at 41,000 shares (US$1.1M). The position peaked in Q3 2026 at 458,954 shares, worth US$94.2M. Across 8 filings, BOOTHBAY FUND MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 458,954 shares valued at US$94.2M — an increase of 403,554 shares quarter over quarter.. Notable position changes include a 81% trim in Q3 2025 (shares rose 71% over the following quarter), a 91% increase in Q1 2026 (shares rose 93% over the following quarter), a 728% increase in Q3 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 41.00K $1.13M New
Q1 2025 175.86K $6.22M New
Q2 2025 185.84K $6.84M Add
Q3 2025 34.50K $1.61M Reduce
Q4 2025 26.40K $2.10M Reduce
Q1 2026 50.30K $4.89M Add
Q2 2026 55.40K $10.38M Add
Q3 2026 458.95K $94.20M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 55 other funds we track also report a position in RVMD — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.75B), Farallon Capital Management (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has BOOTHBAY FUND MANAGEMENT, LLC held RVMD?

BOOTHBAY FUND MANAGEMENT, LLC has disclosed RVMD holdings in 8 of the last 13 reported quarters, going back to Q3 2023.

What is BOOTHBAY FUND MANAGEMENT, LLC's current position in RVMD?

As of Q3 2026, BOOTHBAY FUND MANAGEMENT, LLC holds 458.95K shares of RVMD (REVOLUTION MEDICINES INC), valued at $94.20M, representing 2.32% of its reported portfolio and ranking #1.

Has BOOTHBAY FUND MANAGEMENT, LLC been buying or selling RVMD?

In the latest 13F filing (Q3 2026), BOOTHBAY FUND MANAGEMENT, LLC increased its position in RVMD. The position peaked in Q3 2026 at 458.95K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, BAKER BROS. ADVISORS LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.